Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Leflunomide is more likely to help treat alopecia areata than cause it.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Targeting the AhR pathway may help treat alopecia areata.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

miR-486 may help prevent hair loss in alopecia areata.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.